PURPLE BIOTECH LTD. (PPBT)
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.
Address
4 OPPENHEIMER STREET
REHOVOT, L3 7670104
Founded
1968
Number of Employees
20
Website
http://ww.purple-biotech.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)